Video & Transcript Research : 'study'

Page 13 of 495
AZ

Arizona 2026 Regular Session

02/18/2026 - Senate Health and Human Services

Health and Human Services

Transcript Highlights:
  • The responsibilities of the study committee include conducting a survey and research study to assess
  • The responsibilities of the study committee include conducting a survey and research study to assess
  • And studies confirm common sense here.
  • Studies confirm common sense here.
  • The main thing I'm going to say is study committee. Why are we doing a study committee?
Summary: The committee heard and acted on several health-related bills, with the longest discussion centered on SB 1214, the Arizona Stem Cell Therapy Act. The bill would regulate stem cell and birth tissue therapies, bar use of tissues derived from aborted fetuses or embryos, require informed consent and disclosure for non-FDA-approved therapies, and create civil and criminal penalties for violations. Supporters framed it as a patient-safety and bioscience-innovation measure, while opponents objected to the abortion-related language and felony penalties. The committee approved SB 1214 on a 4-3 vote. The committee also advanced SB 1194, which would prohibit health professionals and institutions from denying care or reducing care quality based on vaccination status, and SB 1814, which creates a study committee on substance use disorder treatment standards and oversight. SB 1602, increasing monthly stipends for kinship foster care parents, and SB 1603, expanding child-only cash assistance eligibility for certain foster and relative placements, were both amended and passed unanimously. SB 1177, barring public funds from being used for gender transition procedures, and SB 1014, requiring insurance coverage for detransition care and related reporting, both drew strong support and opposition and were each approved on 4-3 votes. Later, the committee unanimously passed SB 1628, requiring insurers and health plans to report claims-denial and prior-authorization data to DIFI for public reporting, and SB 1629, requiring AHCCCS managed care organizations to give advance notice and network-adequacy documentation before terminating high-volume providers without cause. Supporters of both bills emphasized transparency and patient access, while opponents argued the measures duplicated existing federal or state oversight. The committee then heard SB 1752, which would criminalize commercial harvesting or sale of mescaline while preserving a religious-use defense; the sponsor said it was intended to address improper sales of peyote-derived substances, but no final action on that bill was taken in the portion provided.
OK

Oklahoma 2026 Regular Session

Public Health Apr 8th, 2026 at 09:00 am

Public Health

Transcript Highlights:
  • Members Senate Bill 1572 is a feasibility study that would designate the state department of health to
  • as commissioner of health and commissioner of mental health during the period of that feasibility study
HI
Transcript Highlights:
  • As noted in our testimony, the Office of the State Auditor released its study last month and found that
  • As noted in our testimony, the Office of the State Auditor released its study last month and found that
  • I believe the auditor study, which we participated in, asked for statistics on type 1, type 2, and gestational
  • 01:34:25.679> believe<01:34:25.760> the<01:34:26.000> auditor<01:34:26.400> study
  • diabetes and I believe the auditor study diabetes and I believe the auditor study which<01:34:26.800
Summary: The committee heard testimony on SB 2047, relating to pharmacy benefit managers. The Insurance Division said the bill would require new enforcement resources and estimated an appropriation of about $1.5 million and five positions. Kaiser Permanente asked for an amendment to exclude HMOs from the definition of third-party PBMs, saying the bill should not interfere with integrated care models. PCMA and the Hawaii Pharmacist Association supported narrowing amendments, with pharmacists objecting to section 3 and warning the bill as amended could create major operational burdens and a significant general fund cost. No vote was taken in the portion provided, and the chair moved on to the next measure after questions. The committee then took up SB 2080, which would allow Hawaii to join the psychology interjurisdictional compact. Supporters, including DCR, the Hawaii Association of Health Plans, the Hawaii State Association of Counties, the Grassroot Institute, and others, said the compact would expand access to psychology services, especially for people in rural areas or those needing continuity of care while traveling. Opponents, including the Board of Psychology and a Shamanad University psychology professor, raised concerns about client safety, crisis-response procedures, enforcement costs, FBI background checks, and possible loss of state control over training and specialization standards. The board said Hawaii’s current 1,900-hour internship/postdoc requirement is higher than the compact’s standard and that the state is still implementing a separate provisional licensing law that may address some access issues. The discussion focused on whether the compact would meaningfully reduce shortages and whether Hawaii should instead pursue changes within its existing licensing system. Finally, the committee heard SB 2277 on hospital price transparency. The Office of Consumer Protection initially noted the bill could require significant staffing, but later testimony from SHIP suggested the measure could be handled more simply by working with the Healthcare Association of Hawaii and publicly posting violations. The Healthcare Association of Hawaii opposed the bill, arguing hospitals already must comply with federal CMS transparency rules and that adding state requirements would increase costs and legal exposure, especially if violations were treated as unfair or deceptive trade practices. Steve Fenberg testified in support, saying the bill would simply codify existing federal requirements in state law and that he was open to amendments removing state enforcement and the unfair trade practice language. No final action was taken in the excerpt provided.
HI

Hawaii 2026 Regular Session

House Chamber - Fri Mar 6, 2026, 12:00PM HST - Day 24

Hawaii House Floor Meeting

Transcript Highlights:
  • be something that we just know all students, all children that we value are able to focus on their studies
  • I know there's studies on both sides and scientists go back and forth, but the prevalent common narrative
  • I know there's studies<00:35:02.160> on<00:35:02.400> both<00:35:02.560> sides<00
  • :35:02.880> and<00:35:03.440> scientists<00:35:04.240> go studies on both sides
  • and scientists go studies on both sides and scientists go back<00:35:04.640> and<00:35:04.800>